Seasonal RotationStarts June 23, biotech. Once any existing shareholders take up any position, rights would automatically yield in favor of the plan. Blame distributors whom have contracts locked up for a decade at a time. Blame partners whom want, or thrown monkeys on PLI back. PLI has disruptive technology, in which are now faced with ramp up, and commercial challenges. The consistency of mixtures, controls, and potential dilution of that consistency the further increase in volume. The best one can hope for is that after the split, the sp rises to the occasion, and perhaps gets bought-out for $100-$350/share...lol.